GLP-1 drugs: what Apple Health paid

Apple Health shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Apple Health's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Apple Health’s payment record shows

In 2026Q1, the product Apple Health paid for most often was liraglutide (generic), at 10,928 prescriptions⁴³ of the 29,936 to 30,080^{1,7,13,19,25,43} across all 8 products, or 37 percent of the published count.

Apple Health itself reimbursed at least $22,983,080 for these products in the quarter, about $768 per prescription. Pharmacies were paid $24,027,453 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,307.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Apple Health finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Apple Health. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Apple Health paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Apple Health paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Fee-for-service	1,808¹	6%	$1,934,275	$1,936,769	$1,070
tirzepatideMounjaro®	Both8,370 managed care, 53 direct	at least 8,423⁷	28%	$8,674,356	$9,168,983	$1,030
semaglutideWegovy®	Both	at least 576¹³	2%	$752,554	$757,559	$1,307
semaglutideOzempic®	Both7,616 managed care, 111 direct	7,727¹⁹	26%	$7,520,174	$8,001,201	$973
semaglutideRybelsus®	Both	at least 458²⁵	2%	$464,407	$496,402	$1,014
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Both10,751 managed care, 177 direct	at least 10,928⁴³	37%	$3,637,315	$3,666,539	$333

Apple Health publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were higher in 2026Q1 than in 2021Q1: 7,727 against 493. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 17.3 to 17.4 prescriptions per thousand people enrolled in Apple Health, on an average of 1,726,267 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 30 of the 168 product-quarters it holds a row for here, which is 18 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Apple Health pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Apple Health paid for each product, quarter by quarter

Prescriptions Apple Health paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³Withheld3 of 3 product codes withheld	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	at least 17 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$17,983 paid	at least 219 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$231,450 paid	at least 624 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$661,650 paid	at least 1,387 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$1,471,215 paid	1,808 paid prescriptions in the quarter (2026Q1)¹Count$1,934,275 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	at least 79 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$59,260 paid	at least 255 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$217,906 paid	at least 548 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$498,290 paid	at least 864 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$827,235 paid	at least 1,085 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$1,055,395 paid	at least 1,410 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$1,369,373 paid	at least 1,597 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$1,612,057 paid	at least 2,091 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$2,093,377 paid	at least 2,693 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$2,536,633 paid	at least 3,303 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$3,201,209 paid	at least 4,045 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$3,988,699 paid	at least 4,495 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$4,487,385 paid	at least 6,159 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$6,128,169 paid	at least 6,983 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$7,049,666 paid	at least 8,423 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$8,674,356 paid
semaglutideWegovy®range 136 to 516	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹⁷Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹⁷Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld5 of 5 product codes withheld	at least 11 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁶At least$14,106 paid	at least 13 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld¹⁵At least$16,835 paid	at least 20 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$25,747 paid	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable¹⁵Withheld4 of 4 product codes withheld	at least 41 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$53,735 paid	136 paid prescriptions in the quarter (2025Q1)¹⁴Count$180,233 paid	at least 230 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$299,145 paid	333 paid prescriptions in the quarter (2025Q3)¹⁴Count$431,196 paid	516 paid prescriptions in the quarter (2025Q4)¹⁴Count$676,825 paid	at least 576 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$752,554 paid
semaglutideOzempic®range 493 to 7,727, up 303 on the quarter before	493 paid prescriptions in the quarter (2021Q1)²⁴Count$387,056 paid	at least 651 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$501,735 paid	897 paid prescriptions in the quarter (2021Q3)²⁴Count$668,971 paid	at least 1,023 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$791,808 paid	1,362 paid prescriptions in the quarter (2022Q1)²³Count$1,033,069 paid	at least 1,743 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$1,289,902 paid	at least 2,243 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$1,933,923 paid	2,401 paid prescriptions in the quarter (2022Q4)²³Count$2,088,548 paid	3,225 paid prescriptions in the quarter (2023Q1)²²Count$2,878,798 paid	4,258 paid prescriptions in the quarter (2023Q2)²²Count$3,761,831 paid	4,189 paid prescriptions in the quarter (2023Q3)²²Count$3,786,167 paid	4,206 paid prescriptions in the quarter (2023Q4)²²Count$3,811,575 paid	4,890 paid prescriptions in the quarter (2024Q1)²¹Count$4,574,318 paid	5,865 paid prescriptions in the quarter (2024Q2)²¹Count$5,450,427 paid	6,390 paid prescriptions in the quarter (2024Q3)²¹Count$5,617,473 paid	6,840 paid prescriptions in the quarter (2024Q4)²¹Count$6,051,460 paid	7,123 paid prescriptions in the quarter (2025Q1)²⁰Count$6,485,531 paid	at least 6,433 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$6,099,466 paid	at least 7,340 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$6,947,900 paid	7,424 paid prescriptions in the quarter (2025Q4)²⁰Count$7,067,235 paid	7,727 paid prescriptions in the quarter (2026Q1)¹⁹Count$7,520,174 paid
semaglutideRybelsus®	at least 56 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$38,878 paid	at least 109 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$82,642 paid	at least 141 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$111,700 paid	at least 168 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$145,868 paid	at least 211 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$171,181 paid	at least 262 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$214,271 paid	at least 341 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$306,947 paid	at least 327 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$319,632 paid	at least 439 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$384,282 paid	at least 512 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$474,105 paid	at least 484 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$457,085 paid	at least 482 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$433,996 paid	at least 479 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$466,012 paid	at least 457 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$444,809 paid	at least 468 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$427,752 paid	at least 477 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$449,071 paid	at least 435 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$461,679 paid	at least 368 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$405,136 paid	at least 388 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$390,347 paid	at least 438 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$440,847 paid	at least 458 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$464,407 paid
liraglutideSaxenda®	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³¹Withheld1 of 1 product codes withheld
liraglutideVictoza®range 5,004 to 16,606	7,690 paid prescriptions in the quarter (2021Q1)⁴²Count$6,529,809 paid	9,100 paid prescriptions in the quarter (2021Q2)⁴²Count$7,789,158 paid	10,259 paid prescriptions in the quarter (2021Q3)⁴²Count$8,780,393 paid	10,769 paid prescriptions in the quarter (2021Q4)⁴²Count$9,356,892 paid	11,553 paid prescriptions in the quarter (2022Q1)⁴¹Count$10,415,353 paid	12,356 paid prescriptions in the quarter (2022Q2)⁴¹Count$11,194,834 paid	13,188 paid prescriptions in the quarter (2022Q3)⁴¹Count$12,132,131 paid	13,620 paid prescriptions in the quarter (2022Q4)⁴¹Count$12,478,092 paid	15,223 paid prescriptions in the quarter (2023Q1)⁴⁰Count$14,554,942 paid	16,606 paid prescriptions in the quarter (2023Q2)⁴⁰Count$15,835,174 paid	16,256 paid prescriptions in the quarter (2023Q3)⁴⁰Count$14,995,279 paid	16,152 paid prescriptions in the quarter (2023Q4)⁴⁰Count$14,933,624 paid	12,917 paid prescriptions in the quarter (2024Q1)³⁹Count$8,849,074 paid	12,539 paid prescriptions in the quarter (2024Q2)³⁹Count$8,432,261 paid	5,004 paid prescriptions in the quarter (2024Q3)³⁹Count$3,304,781 paid	at least 2,729 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$1,913,512 paid	at least 684 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$441,031 paid	at least 183 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³⁸At least$118,556 paid	at least 12 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld³⁸At least$5,503 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³⁷Withheld3 of 3 product codes withheld
liraglutideliraglutide (generic)range 82 to 12,961	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	82 paid prescriptions in the quarter (2024Q2)⁴⁵Count$58,613 paid	8,116 paid prescriptions in the quarter (2024Q3)⁴⁵Count$4,314,996 paid	at least 10,934 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$5,997,839 paid	12,961 paid prescriptions in the quarter (2025Q1)⁴⁴Count$6,901,349 paid	at least 11,859 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$5,115,229 paid	11,247 paid prescriptions in the quarter (2025Q3)⁴⁴Count$3,456,309 paid	at least 11,606 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$3,161,834 paid	at least 10,928 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$3,637,315 paid

What this page cannot tell you

Whether Apple Health covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Washington in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, WA
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state WA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND 5", "suppression_used": "false", "number_of_prescriptions": "501"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, WA
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state WA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "525"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, WA
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state WA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "ZEPBOUND 7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, WA
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state WA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, WA
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state WA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "product_name": "product_name like ZEPBOUND%, state WA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, WA
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state WA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "product_name": "product_name like ZEPBOUND%, state WA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, WA
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state WA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1731"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, WA
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state WA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1508"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, WA
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state WA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "782"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, WA
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state WA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "333"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, WA
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state WA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "96"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, WA
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state WA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "product_name": "product_name like MOUNJARO%, state WA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, WA
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state WA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 1 M", "suppression_used": "false", "number_of_prescriptions": "153"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, WA
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state WA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "156"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, WA
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state WA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "29"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, WA
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state WA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, WA
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state WA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, WA
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state WA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.5", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, WA
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state WA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2 ", "suppression_used": "false", "number_of_prescriptions": "3340"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, WA
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state WA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 2 ", "suppression_used": "false", "number_of_prescriptions": "3158"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, WA
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state WA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 2 ", "suppression_used": "false", "number_of_prescriptions": "2535"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, WA
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state WA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "1764"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, WA
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state WA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "1191"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, WA
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state WA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "526"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, WA
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state WA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "235"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, WA
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state WA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "253"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, WA
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state WA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "225"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, WA
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state WA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "230"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, WA
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state WA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "141"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, WA
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state WA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "72"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, WA
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state WA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, WA
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state WA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, WA
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state WA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, WA
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state WA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, WA
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state WA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, WA
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state WA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, WA
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state WA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, WA
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state WA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "468"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, WA
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state WA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "7868"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, WA
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state WA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "9137"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, WA
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state WA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "7793"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, WA
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state WA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "6174"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, WA
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state WA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "2458"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, WA
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state WA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "5715"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, WA
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state WA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "6678"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, WA
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state WA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "product_name": "product_name like LIRAGLUTID%, state WA, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, WA
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state WA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "product_name": "product_name like LIRAGLUTID%, state WA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, WA
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state WA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WA", "product_name": "product_name like LIRAGLUTID%, state WA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 42 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 6 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Apple Health covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.